SEC Form 4 research
| Issuer | Tyra Biosciences, Inc. |
|---|---|
| Tickers | TYRA |
| Reporting owners | 48 |
| Officers and directors | 8 |
| Last public filing | 2026-09-17 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-17 | 2026-09-15 | Harris Todd | A | 864 | $9.13 | Not reported |
| 2026-09-17 | 2026-09-15 | Rueb Yuliya | A | 2,925 | $9.13 | Not reported |
| 2026-09-17 | 2026-09-15 | Fuhrman Alan | A | 951 | $9.13 | Not reported |
| 2026-09-17 | 2026-09-15 | Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Shah Rajeev M. | P | 9,078,529 | $22.03 | Not reported |
| 2026-09-11 | 2026-09-09 | Verjee Rehan | P | 971.89 | $20.58 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.